Anti HER2/PD-L1 bispecific antibody (Fontacea )

HER2/PD-L1双特异性抗体（方坦思）

Report date: 2021/12/08 14:19:51

Base Information

Drug NameAnti HER2/PD-L1 bispecific antibody (Fontacea )
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 blockersReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsProgrammed death-ligand 1Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Fontacea Pharmaceutical Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Fontacea Pharmaceutical Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A